Using a wearable device to monitor gait in nursing home residents
Using Gait Data to Inform Prescription Practice Among Nursing Home Residents to Reduce Medication-Induced Gait Disturbances
NA · University of Pittsburgh · NCT06665685
This study is testing a wearable device to see if it can help nursing home residents with multiple medications by monitoring their walking patterns to prevent falls.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 70 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Pittsburgh (other) |
| Locations | 1 site (Pittsburgh, Pennsylvania) |
| Trial ID | NCT06665685 on ClinicalTrials.gov |
What this trial studies
This pilot study investigates the effectiveness of the BioIntellisense BioButton, a remote wearable multi-parameter monitor, in detecting gait disturbances caused by polypharmacy among nursing home residents. With the increasing risk of falls in the elderly population, particularly those on multiple medications, this study aims to provide clinicians with valuable gait data to inform medication decisions. By collecting and analyzing gait data, the study seeks to enhance the safety and well-being of older adults in nursing homes, ultimately reducing fall-related injuries and healthcare costs.
Who should consider this trial
Good fit: Ideal candidates for this study are nursing home residents over 18 years old who have documented gait issues in their electronic medical records.
Not a fit: Patients who are bedbound, unable to stand, or cannot provide consent due to cognitive status may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved medication management and reduced fall risk for nursing home residents.
How similar studies have performed: While this approach is innovative, similar studies have shown promise in using wearable technology to monitor health parameters in elderly populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \>18yrs * Presence of gait documentation in EMR Exclusion Criteria: * Age \<18yrs * Non-English-speaking patients * Patients who cannot provide consent due to cognitive status * Bedbound, unable to stand
Where this trial is running
Pittsburgh, Pennsylvania
- UPMC Canterbury Place — Pittsburgh, Pennsylvania, United States (RECRUITING)
Study contacts
- Principal investigator: Charles Lin, MD — UPMC, University of Pittsburgh
- Study coordinator: Carly Riedmann, MPH
- Email: riedmannca@upmc.edu
- Phone: 412-623-4147
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Gait, Medication Induced Gait Disturbances